MovDisordV3, Main, Exploration, bibRecord, 001809

Anhedonia in Parkinson's disease: A systematic review of the literature

Identifieur interne : 001809 ( Main/Exploration ); précédent : 001808; suivant : 001810

Anhedonia in Parkinson's disease: A systematic review of the literature

Auteurs : Francesca Assogna [Italie] ; Luca Cravello [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie]

Source :

Movement Disorders [ 0885-3185 ] ; 2011-08-15.

RBID : ISTEX:421FBAEB8FF7D06CFDB87BAE55B88EBEEB34F486

Descripteurs français

Pascal (Inist)
- Anhédonie, Apathie, Etat dépressif, Maladie de Parkinson, Pathologie du système nerveux, Trouble cognitif, Trouble moteur.

English descriptors

KwdEn :
- Anhedonia, Anhedonia (drug effects), Anhedonia (physiology), Apathy, Cognitive disorder, Databases, Bibliographic (statistics & numerical data), Depression, Dopamine (metabolism), Dopamine Agents (pharmacology), Dopamine Agents (therapeutic use), Humans, Mental Disorders (complications), Motor system disorder, Nervous system diseases, Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson Disease (psychology), Parkinson disease, Parkinson's disease, anhedonia, apathy, cognitive deficits, depression, motor symptoms, nonmotor symptoms.
MESH :
- chemical , metabolism : Dopamine.
- complications : Mental Disorders.
- drug effects : Anhedonia.
- drug therapy : Parkinson Disease.
- chemical , pharmacology : Dopamine Agents.
- physiology : Anhedonia.
- physiopathology : Parkinson Disease.
- psychology : Parkinson Disease.
- statistics & numerical data : Databases, Bibliographic.
- chemical , therapeutic use : Dopamine Agents.
- Humans.

Abstract

Anhedonia, defined as lowered ability to experience physical or social pleasure, is a key symptom of several psychiatric illnesses. In this systematic review, we aimed to evaluate the role of anhedonia in Parkinson's Disease and its relationships with other clinical characteristics, dopamine dysfunction, and antiparkinsonian therapy. The database was selected using PubMed Services. Relevant journals were hand‐searched, and the bibliographies of all the important articles were scrutinized to find additional publications. Fifteen studies assessed the topic of anhedonia in Parkinson's disease from 1984 to 2009 and mainly described it as a core symptom of depression in patients with Parkinson's disease. Some studies investigated the relationship between anhedonia and neuropsychological symptoms and found correlations with frontal lobe functions. Reports on the relationship between anhedonia and illness severity or motor symptoms are rather inconclusive. No definitive conclusions can be drawn because few studies have been published on this topic. Nevertheless, some evidence suggests that in Parkinson's disease anhedonia is a secondary phenomenon linked to depression, apathy severity, and frontal lobe dysregulation and that it could respond to antiparkinsonian treatment. Future studies of larger samples of patients are strongly required to definitively clarify the relationship between anhedonia and other clinical features, such as depression, anxiety, apathy, cognition, and motor status. Furthermore, more reliable tools and validated diagnostic criteria are necessary to assess anhedonia in patients with Parkinson's disease. © 2011 Movement Disorder Society

Url:

https://api.istex.fr/document/421FBAEB8FF7D06CFDB87BAE55B88EBEEB34F486/fulltext/pdf

DOI: 10.1002/mds.23815

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Anhedonia in Parkinson's disease: A systematic review of the literature</title>
<author><name sortKey="Assogna, Francesca" sort="Assogna, Francesca" uniqKey="Assogna F" first="Francesca" last="Assogna">Francesca Assogna</name>
</author>
<author><name sortKey="Cravello, Luca" sort="Cravello, Luca" uniqKey="Cravello L" first="Luca" last="Cravello">Luca Cravello</name>
</author>
<author><name sortKey="Caltagirone, Carlo" sort="Caltagirone, Carlo" uniqKey="Caltagirone C" first="Carlo" last="Caltagirone">Carlo Caltagirone</name>
</author>
<author><name sortKey="Spalletta, Gianfranco" sort="Spalletta, Gianfranco" uniqKey="Spalletta G" first="Gianfranco" last="Spalletta">Gianfranco Spalletta</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:421FBAEB8FF7D06CFDB87BAE55B88EBEEB34F486</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23815</idno>
<idno type="url">https://api.istex.fr/document/421FBAEB8FF7D06CFDB87BAE55B88EBEEB34F486/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000310</idno>
<idno type="wicri:Area/Istex/Curation">000310</idno>
<idno type="wicri:Area/Istex/Checkpoint">000542</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Assogna F:anhedonia:in:parkinson</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:21661052</idno>
<idno type="wicri:Area/PubMed/Corpus">001135</idno>
<idno type="wicri:Area/PubMed/Curation">001135</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001475</idno>
<idno type="wicri:Area/Ncbi/Merge">003293</idno>
<idno type="wicri:Area/Ncbi/Curation">003293</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003293</idno>
<idno type="wicri:Area/Main/Merge">001863</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:11-0402015</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000452</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002866</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000714</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Assogna F:anhedonia:in:parkinson</idno>
<idno type="wicri:Area/Main/Merge">001D04</idno>
<idno type="wicri:Area/Main/Curation">001809</idno>
<idno type="wicri:Area/Main/Exploration">001809</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Anhedonia in Parkinson's disease: A systematic review of the literature</title>
<author><name sortKey="Assogna, Francesca" sort="Assogna, Francesca" uniqKey="Assogna F" first="Francesca" last="Assogna">Francesca Assogna</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>I.R.C.C.S. Santa Lucia Foundation, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cravello, Luca" sort="Cravello, Luca" uniqKey="Cravello L" first="Luca" last="Cravello">Luca Cravello</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>I.R.C.C.S. Santa Lucia Foundation, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Caltagirone, Carlo" sort="Caltagirone, Carlo" uniqKey="Caltagirone C" first="Carlo" last="Caltagirone">Carlo Caltagirone</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>I.R.C.C.S. Santa Lucia Foundation, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University “Tor Vergata,” Rome</wicri:regionArea>
<wicri:noRegion>” Rome</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Spalletta, Gianfranco" sort="Spalletta, Gianfranco" uniqKey="Spalletta G" first="Gianfranco" last="Spalletta">Gianfranco Spalletta</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>I.R.C.C.S. Santa Lucia Foundation, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-08-15">2011-08-15</date>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="1825">1825</biblScope>
<biblScope unit="page" to="1834">1834</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">421FBAEB8FF7D06CFDB87BAE55B88EBEEB34F486</idno>
<idno type="DOI">10.1002/mds.23815</idno>
<idno type="ArticleID">MDS23815</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anhedonia</term>
<term>Anhedonia (drug effects)</term>
<term>Anhedonia (physiology)</term>
<term>Apathy</term>
<term>Cognitive disorder</term>
<term>Databases, Bibliographic (statistics & numerical data)</term>
<term>Depression</term>
<term>Dopamine (metabolism)</term>
<term>Dopamine Agents (pharmacology)</term>
<term>Dopamine Agents (therapeutic use)</term>
<term>Humans</term>
<term>Mental Disorders (complications)</term>
<term>Motor system disorder</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>anhedonia</term>
<term>apathy</term>
<term>cognitive deficits</term>
<term>depression</term>
<term>motor symptoms</term>
<term>nonmotor symptoms</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Mental Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Anhedonia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Dopamine Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Anhedonia</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Databases, Bibliographic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agents</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Anhédonie</term>
<term>Apathie</term>
<term>Etat dépressif</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Trouble cognitif</term>
<term>Trouble moteur</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Anhedonia, defined as lowered ability to experience physical or social pleasure, is a key symptom of several psychiatric illnesses. In this systematic review, we aimed to evaluate the role of anhedonia in Parkinson's Disease and its relationships with other clinical characteristics, dopamine dysfunction, and antiparkinsonian therapy. The database was selected using PubMed Services. Relevant journals were hand‐searched, and the bibliographies of all the important articles were scrutinized to find additional publications. Fifteen studies assessed the topic of anhedonia in Parkinson's disease from 1984 to 2009 and mainly described it as a core symptom of depression in patients with Parkinson's disease. Some studies investigated the relationship between anhedonia and neuropsychological symptoms and found correlations with frontal lobe functions. Reports on the relationship between anhedonia and illness severity or motor symptoms are rather inconclusive. No definitive conclusions can be drawn because few studies have been published on this topic. Nevertheless, some evidence suggests that in Parkinson's disease anhedonia is a secondary phenomenon linked to depression, apathy severity, and frontal lobe dysregulation and that it could respond to antiparkinsonian treatment. Future studies of larger samples of patients are strongly required to definitively clarify the relationship between anhedonia and other clinical features, such as depression, anxiety, apathy, cognition, and motor status. Furthermore, more reliable tools and validated diagnostic criteria are necessary to assess anhedonia in patients with Parkinson's disease. © 2011 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Italie</li>
</country>
<region><li>Latium</li>
</region>
<settlement><li>Rome</li>
</settlement>
</list>
<tree><country name="Italie"><region name="Latium"><name sortKey="Assogna, Francesca" sort="Assogna, Francesca" uniqKey="Assogna F" first="Francesca" last="Assogna">Francesca Assogna</name>
</region>
<name sortKey="Caltagirone, Carlo" sort="Caltagirone, Carlo" uniqKey="Caltagirone C" first="Carlo" last="Caltagirone">Carlo Caltagirone</name>
<name sortKey="Caltagirone, Carlo" sort="Caltagirone, Carlo" uniqKey="Caltagirone C" first="Carlo" last="Caltagirone">Carlo Caltagirone</name>
<name sortKey="Cravello, Luca" sort="Cravello, Luca" uniqKey="Cravello L" first="Luca" last="Cravello">Luca Cravello</name>
<name sortKey="Spalletta, Gianfranco" sort="Spalletta, Gianfranco" uniqKey="Spalletta G" first="Gianfranco" last="Spalletta">Gianfranco Spalletta</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001809 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001809 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:421FBAEB8FF7D06CFDB87BAE55B88EBEEB34F486
   |texte=   Anhedonia in Parkinson's disease: A systematic review of the literature
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Anhedonia in Parkinson's disease: A systematic review of the literature

Anhedonia in Parkinson's disease: A systematic review of the literature

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.